Škrott Zdeněk Ph.D.
Journals
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
Oncogene.
2019,
38(40),
6711-6722,
ISSN: 0950-9232,
PMID: 31391554,
Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram.
The Prostate.
2018,
79(4),
352-362,
ISSN: 0270-4137,
PMID: 30499118,
Open positions
Project: | Cellular stress in health and disease |
---|---|
Supervisors: | Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D. |
Available: | 3 |
Intended for: | Doctoral training |